Why Are NanoString Technologies Shares Falling Today
Portfolio Pulse from Vandana Singh
10x Genomics Inc (NASDAQ:TXG) won an injunction against NanoString Technologies Inc (NASDAQ:NSTG) in a patent litigation case, forcing NanoString to stop selling its CosMx Spatial Molecular Imager instrument and RNA detection reagents in Germany. The decision is limited to Germany and does not apply to using the CosMx SMI instrument to detect proteins.
May 18, 2023 | 4:57 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NanoString Technologies Inc (NASDAQ:NSTG) is forced to stop selling its CosMx Spatial Molecular Imager instrument and RNA detection reagents in Germany due to a patent litigation loss.
NanoString lost the patent litigation case against 10x Genomics, which will negatively impact its sales and revenue in Germany. This has led to a 20.60% drop in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
10x Genomics Inc (NASDAQ:TXG) won an injunction against NanoString Technologies Inc in a patent litigation case, forcing NanoString to stop selling its CosMx Spatial Molecular Imager instrument and RNA detection reagents in Germany.
10x Genomics won the patent litigation case against NanoString, which will limit NanoString's sales and revenue in Germany. This has led to a 4.02% increase in 10x Genomics' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100